Mirtazapine Tablet, Film Coated
Product Images NDC 70518-4322

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 70518-4322). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label for Mirtazapine 15 mg oral film-coated tablets, containing 30 tablets. The label includes the NDC 70518-4322-00, with manufacturer information listing Mylan Pharma Inc. The label advises protection from light and moisture and notes repackaging by RemedyRepack Inc., Indiana, PA.*

FDA Label Image

Mirtazapine Structural Formula (Image 04)

Chemical structure diagram of mirtazapine, showing the arrangement of its fused ring system with nitrogen atoms, including a methyl group attached to a piperazine ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.